Home LiteratureArticle Details
PMID: 3621221 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study.

Cancer treatment reports ·Vol. 71 ·No. 9 ·1987-09-00 ·Pages 869-70

Slayton RE, Blessing JA, Beecham J, DiSaia PJ

Abstract

暂无摘要

MeSH Terms
Adult Aged Aged, 80 and over Carcinoma/drug therapy Carcinoma, Squamous Cell/drug therapy Drug Evaluation Etoposide/therapeutic use Female Humans Middle Aged Neoplasm Recurrence, Local Vaginal Neoplasms/drug therapy Vulvar Neoplasms/drug therapy
Chemicals
Etoposide
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Slayton R E
Blessing J A
Beecham J
DiSaia P J
Article Info
Journal
Cancer treatment reports
Abbr.
Cancer Treat Rep
ISSN
0361-5960
Published
1987-09-00
Pages
869-70
Language
English
Region
United States
NLM ID
7607107
Subset
IM
Grants
NCI NIH HHS · CA-12478 · United States
NCI NIH HHS · CA-12484 · United States
NCI NIH HHS · CA-12534 · United States
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2